IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice
Authors:
- 1 June 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 112 (3) , 397-402
Abstract
In the present study, we examined the preventive effect of anti-mouse IL-6 receptor (IL-6R) antibody, MR16-1, on the development of autoimmune kidney disease in female NZB/W F1 (BWF1) mice. Immunological tolerance to MR16-1 or isotype-matched control antibody, KH-5, was induced by the simultaneous administration of anti-CD4 MoAb in mice. Thereafter, mice were intraperitoneally given 0.5 mg of MR16-1, 0.5 mg of KH-5 or saline once a week from 13 to 64 weeks of age. MR16-1 treatment dramatically suppressed proteinuria and prolonged the survival time of BWF1 mice. Only one out of 10 mice died with high levels of proteinuria throughout the experiment. MR16-1 almost completely suppressed the production of IgG forms of anti-DNA and anti-TNP antibodies, but not the IgM forms of these antibodies. In particular, all IgG subclasses (IgG1, IgG2a, IgG2b and IgG3) of anti-DNA antibody production were significantly suppressed. Moreover, serum IgG1, IgG2a and IgG3 levels in MR16-1-treated mice were lower than those in saline- and KH-5-treated mice, whereas serum IgM and IgA levels were not influenced. In conclusion, MR16-1 potently suppressed the development of autoimmune disease in BWF1 mice, and this was attributed to its effect of specific suppression of IgG class antibody production.Keywords
This publication has 32 references indexed in Scilit:
- Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.Journal of Clinical Investigation, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Protective effect of anti‐interleukin (IL)‐6 antibody against endotoxin, associated with paradoxically increased IL‐6 levelsEuropean Journal of Immunology, 1992
- Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB × NZW)F1 hybridClinical Immunology and Immunopathology, 1992
- Immunologic abnormality in NZB/W Fl mice. Thymus-independent expansion of B cells responding to interleukin-6Clinical and Experimental Immunology, 1990
- Possible Role of IL-6 in Pathogenesis of Immune Complex-Mediated Glomerulonephritis in NZB/W F1 Mice: Induction of IgG Class Anti-DNA Autoantibody ProductionInternational Archives of Allergy and Immunology, 1990
- Endogenous interleukin 6 plays an obligatory role in interleukin 4‐dependent human IgE synthesisEuropean Journal of Immunology, 1989
- The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.Journal of Experimental Medicine, 1988
- An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): Inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr miceClinical Immunology and Immunopathology, 1987
- Low-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid mice.Journal of Experimental Medicine, 1981